{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T07:10:31Z","timestamp":1776669031273,"version":"3.51.2"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Direcci\u00f3n de Investigaci\u00f3n, Universidad Peruana de Ciencias Aplicadas","award":["grant N\u00ba UPC- C-024-2019"],"award-info":[{"award-number":["grant N\u00ba UPC- C-024-2019"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-026-04847-6","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:26:29Z","timestamp":1773235589000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetic variants of AcrAB and OqxAB and the impact of efflux pump inhibition on ciprofloxacin and amikacin resistance in clinical isolates of Klebsiella pneumoniae from Lima, Peru"],"prefix":"10.1186","volume":"26","author":[{"given":"Deysi","family":"Aguilar-Luis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilmer","family":"Silva-Caso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giancarlo","family":"P\u00e9rez-Lazo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liliana","family":"Morales-Castillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Camps","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Soto-Febres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel Angel","family":"Aguilar-Luis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Aquino-Ortega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juana","family":"del Valle-Mendoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"key":"4847_CR1","doi-asserted-by":"publisher","first-page":"103998","DOI":"10.1016\/j.ebiom.2022.103998","volume":"79","author":"N Dong","year":"2022","unstructured":"Dong N, Yang X, Chan EW, Zhang R, Chen S. Klebsiella species: Taxonomy, hypervirulence and multidrug resistance. EBioMedicine. 2022;79:103998.","journal-title":"EBioMedicine"},{"issue":"6","key":"4847_CR2","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/s41579-019-0315-1","volume":"18","author":"KL Wyres","year":"2020","unstructured":"Wyres KL, Lam MMC, Holt KE. Population genomics of Klebsiella pneumoniae. Nat Rev Microbiol. 2020;18(6):344\u201359.","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"4847_CR3","doi-asserted-by":"publisher","first-page":"20230707","DOI":"10.1515\/med-2023-0707","volume":"18","author":"Y Li","year":"2023","unstructured":"Li Y, Kumar S, Zhang L, Wu H, Wu H. Characteristics of antibiotic resistance mechanisms and genes of Klebsiella pneumoniae. Open Med (Wars). 2023;18(1):20230707.","journal-title":"Open Med (Wars)"},{"issue":"3","key":"4847_CR4","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1128\/MMBR.00078-15","volume":"80","author":"MK Paczosa","year":"2016","unstructured":"Paczosa MK, Mecsas J. Klebsiella pneumoniae: going on the offense with a strong defense. Microbiol Mol Biol Rev. 2016;80(3):629\u201361.","journal-title":"Microbiol Mol Biol Rev"},{"key":"4847_CR5","doi-asserted-by":"publisher","first-page":"750662","DOI":"10.3389\/fmicb.2021.750662","volume":"12","author":"D Chang","year":"2021","unstructured":"Chang D, Sharma L, Dela Cruz CS, Zhang D, Clinical, Epidemiology. Risk Factors, and control strategies of Klebsiella pneumoniae infection. Front Microbiol. 2021;12:750662.","journal-title":"Front Microbiol"},{"issue":"1","key":"4847_CR6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12941-017-0191-3","volume":"16","author":"L Xu","year":"2017","unstructured":"Xu L, Sun X, Ma X. Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae. Ann Clin Microbiol Antimicrob. 2017;16(1):18.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"3","key":"4847_CR7","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","volume":"18","author":"E Tacconelli","year":"2018","unstructured":"Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Pulcini C, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3):318\u201327. https:\/\/doi.org\/10.1016\/S1473-3099(17)30753-3.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"4847_CR8","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1086\/313719","volume":"30","author":"DL Paterson","year":"2000","unstructured":"Paterson DL, Mulazimoglu L, Casellas JM, Ko WC, Goossens H, Von Gottberg A, Mohapatra S, Trenholme GM, Klugman KP, McCormack JG, Yu VL. Epidemiology of Ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin Infect Dis. 2000;30(3):473\u20138.","journal-title":"Clin Infect Dis"},{"key":"4847_CR9","doi-asserted-by":"publisher","first-page":"h6420","DOI":"10.1136\/bmj.h6420","volume":"352","author":"J Iredell","year":"2016","unstructured":"Iredell J, Brown J, Tagg K. Antibiotic resistance in enterobacteriaceae: mechanisms and clinical implications. BMJ. 2016;352:h6420.","journal-title":"BMJ"},{"key":"4847_CR10","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3389\/fmicb.2015.00377","volume":"6","author":"H Venter","year":"2015","unstructured":"Venter H, Mowla R, Ohene-Agyei T, Ma S. RND-type drug efflux pumps from Gram-negative bacteria: molecular mechanism and Inhibition. Front Microbiol. 2015;6:377.","journal-title":"Front Microbiol"},{"key":"4847_CR11","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2217\/fmb-2019-0235","volume":"15","author":"AL Colclough","year":"2020","unstructured":"Colclough AL, Alav I, Whittle EE, Pugh HL, Darby EM, Legood SW, McNeil HE, Blair JM. RND efflux pumps in Gram-negative bacteria; regulation, structure and role in antibiotic resistance. Future Microbiol. 2020;15:143\u201357.","journal-title":"Future Microbiol"},{"key":"4847_CR12","doi-asserted-by":"publisher","first-page":"10731","DOI":"10.1038\/ncomms10731","volume":"7","author":"L Daury","year":"2016","unstructured":"Daury L, Orange F, Taveau JC, Verch\u00e8re A, Monlezun L, Gounou C, Marreddy RK, Picard M, Broutin I, Pos KM, Lambert O. Tripartite assembly of RND multidrug efflux pumps. Nat Commun. 2016;7:10731.","journal-title":"Nat Commun"},{"key":"4847_CR13","doi-asserted-by":"crossref","unstructured":"Auda IG, Salman IMA, Odah J. Efflux pumps of Gram-negative bacteria in brief Gene Rep. 2020, pp. 1\u201311.","DOI":"10.1016\/j.genrep.2020.100666"},{"issue":"2","key":"4847_CR14","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1128\/CMR.00117-14","volume":"28","author":"XZ Li","year":"2015","unstructured":"Li XZ, Pl\u00e9siat P, Nikaido H. The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria. Clin Microbiol Rev. 2015;28(2):337\u2013418.","journal-title":"Clin Microbiol Rev"},{"issue":"12","key":"4847_CR15","doi-asserted-by":"publisher","first-page":"3984","DOI":"10.1128\/AAC.46.12.3984-3986.2002","volume":"46","author":"A Mazzariol","year":"2002","unstructured":"Mazzariol A, Zuliani J, Cornaglia G, Rossolini GM, Fontana R. AcrAB efflux system: expression and contribution to fluoroquinolone resistance in Klebsiella spp. Antimicrob Agents Chemother. 2002;46(12):3984\u20136.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"4847_CR16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1128\/AAC.00715-09","volume":"54","author":"E Padilla","year":"2010","unstructured":"Padilla E, Llobet E, Dom\u00e9nech A, Mart\u00ednez L, Bengoechea J, Albert\u00ed S. Klebsiella pneumoniae acrab efflux pump contributes to antimicrobial resistance and virulence. Antimicrob Agents Chemother. 2010;54(1):177\u201383.","journal-title":"Antimicrob Agents Chemother"},{"key":"4847_CR17","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13756-019-0489-3","volume":"8","author":"J Li","year":"2019","unstructured":"Li J, Zhang H, Ning J, Sajid A, Cheng G, Yuan Z, Hao H. The nature and epidemiology of OqxAB, a multidrug efflux pump. Antimicrob Resist Infect Control. 2019;8:44.","journal-title":"Antimicrob Resist Infect Control"},{"key":"4847_CR18","doi-asserted-by":"crossref","unstructured":"Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, van Duin D, Clancy CJ. Infectious diseases society of America 2023 guidance on the treatment of antimicrobial resistant Gram-Negative infections. Clin Infect Dis 2023 Jul 18:ciad428.","DOI":"10.1093\/cid\/ciad428"},{"key":"4847_CR19","doi-asserted-by":"crossref","unstructured":"Albarri O, AlMatar M, Var I, K\u00f6ksal F. Antimicrobial resistance of clinical Klebsiella pneumoniae isolates: involvement of acrab and OqxAB efflux pumps. Curr Mol Pharmacol. 2023 Mar 31.","DOI":"10.2174\/1874467217666230331081434"},{"key":"4847_CR20","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3389\/fmicb.2017.00228","volume":"8","author":"J Osei Sekyere","year":"2017","unstructured":"Osei Sekyere J, Amoako DG. Carbonyl cyanide m-Chlorophenylhydrazine (CCCP) reverses resistance to Colistin, but not to carbapenems and Tigecycline in Multidrug-Resistant Enterobacteriaceae. Front Microbiol. 2017;8:228.","journal-title":"Front Microbiol"},{"issue":"2","key":"4847_CR21","first-page":"Doc15","volume":"8","author":"I Pakzad","year":"2013","unstructured":"Pakzad I, Zayyen Karin M, Taherikalani M, Boustanshenas M, Lari AR. Contribution of acrab efflux pump to Ciprofloxacin resistance in Klebsiella pneumoniae isolated from burn patients. GMS Hyg Infect Control. 2013;8(2):Doc15.","journal-title":"GMS Hyg Infect Control"},{"key":"4847_CR22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jgar.2017.12.003","volume":"12","author":"A Vera-Leiva","year":"2018","unstructured":"Vera-Leiva A, Carrasco-Anabal\u00f3n S, Lima CA, Villagra N, Dom\u00ednguez M, Bello-Toledo H, Gonz\u00e1lez-Rocha G. The efflux pump inhibitor phenylalanine-arginine \u03b2-naphthylamide (PA\u03b2N) increases resistance to carbapenems in Chilean clinical isolates of KPC-producing Klebsiella pneumoniae. J Glob Antimicrob Resist. 2018;12:73\u20136.","journal-title":"J Glob Antimicrob Resist"},{"issue":"6","key":"4847_CR23","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.3390\/antibiotics12061071","volume":"12","author":"S Plasencia-Rebata","year":"2023","unstructured":"Plasencia-Rebata S, Levy-Blitchtein S, Del Valle-Mendoza J, Silva-Caso W, Pe\u00f1a-Tuesta I, Vicente Taboada W, Barreda Bola\u00f1os F, Aguilar-Luis MA. Effect of Phenylalanine-Arginine Beta-Naphthylamide on the values of minimum inhibitory concentration of quinolones and aminoglycosides in clinical isolates of acinetobacter baumannii. Antibiot (Basel). 2023;12(6):1071.","journal-title":"Antibiot (Basel)"},{"issue":"12","key":"4847_CR24","doi-asserted-by":"publisher","first-page":"e0259915","DOI":"10.1371\/journal.pone.0259915","volume":"16","author":"A Sanchez-Carbonel","year":"2021","unstructured":"Sanchez-Carbonel A, Mondrag\u00f3n B, L\u00f3pez-Chegne N, Pe\u00f1a-Tuesta I, Huayan-D\u00e1vila G, Blitchtein D, Carrillo-Ng H, Silva-Caso W, Aguilar-Luis MA, Del Valle-Mendoza J. The effect of the efflux pump inhibitor carbonyl cyanide m-Chlorophenylhydrazone (CCCP) on the susceptibility to Imipenem and cefepime in clinical strains of acinetobacter baumannii. PLoS ONE. 2021;16(12):e0259915.","journal-title":"PLoS ONE"},{"key":"4847_CR25","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12866-015-0396-6","volume":"15","author":"U Garza-Ramos","year":"2015","unstructured":"Garza-Ramos U, Silva-S\u00e1nchez J, Mart\u00ednez-Romero E, Tinoco P, Pina-Gonzales M, Barrios H, Mart\u00ednez-Barnetche J, G\u00f3mez-Barreto RE, Tellez-Sosa J. Development of a multiplex-PCR probe system for the proper identification of Klebsiella variicola. BMC Microbiol. 2015;15:64.","journal-title":"BMC Microbiol"},{"key":"4847_CR26","volume-title":"M07-A10. Methods for Dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard","author":"Clinical and Laboratory Standards Institute","year":"2015","unstructured":"Clinical and Laboratory Standards Institute. M07-A10. Methods for Dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 10th ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2015.","edition":"10"},{"key":"4847_CR27","volume-title":"M100-S26. Performance standards for antimicrobial susceptibility testing: 26th informational supplement","author":"Clinical and Laboratory Standards Institute","year":"2016","unstructured":"Clinical and Laboratory Standards Institute. M100-S26. Performance standards for antimicrobial susceptibility testing: 26th informational supplement. Wayne, PA: Clinical and Laboratory Standards Institute; 2016."},{"issue":"10","key":"4847_CR28","doi-asserted-by":"publisher","first-page":"e19048","DOI":"10.5812\/jjm.19048","volume":"8","author":"M Gholami","year":"2015","unstructured":"Gholami M, Hashemi A, Hakemi-Vala M, Goudarzi H, Hallajzadeh M. Efflux pump inhibitor Phenylalanine-Arginine \u0392-Naphthylamide effect on the minimum inhibitory concentration of Imipenem in acinetobacter baumannii strains isolated from hospitalized patients in Shahid Motahari burn Hospital, Tehran, Iran. Jundishapur J Microbiol. 2015;8(10):e19048.","journal-title":"Jundishapur J Microbiol"},{"issue":"5","key":"4847_CR29","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1093\/jac\/dkl081","volume":"57","author":"S Pannek","year":"2006","unstructured":"Pannek S, Higgins PG, Steinke P, Jonas D, Akova M, Bohnert JA, et al. Multidrug efflux Inhibition in acinetobacter baumannii: comparison between 1-(1-naphthylmethyl)-piperazine and phenyl-arginine-beta-naphthylamide. J Antimicrob Chemother. 2006;57(5):970\u20134.","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"4847_CR30","first-page":"251","volume":"7","author":"S Razavi","year":"2020","unstructured":"Razavi S, Mirnejad R, Babapour E. Involvement of acrab and OqxAB efflux pumps in antimicrobial resistance of clinical isolates of Klebsiella pneumonia. J Appl Biotechnol Rep. 2020;7(4):251\u20137.","journal-title":"J Appl Biotechnol Rep"},{"key":"4847_CR31","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.2147\/IDR.S509016","volume":"18","author":"J Li","year":"2025","unstructured":"Li J, Shi Y, Song X, Yin X, Liu H. Mechanisms of antimicrobial resistance in Klebsiella: advances in detection methods and clinical implications. Infect Drug Resist. 2025;18:1339\u201354.","journal-title":"Infect Drug Resist"},{"issue":"10","key":"4847_CR32","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.4067\/S0034-98872004001000003","volume":"132","author":"P D\u00edaz","year":"2004","unstructured":"D\u00edaz P, Bello H, Dominguez M, Trabal N, Mella S, Zemelman R, et al. Resistance to gentamicin, Amikacin and Ciprofloxacin among nosocomial isolates of Klebsiella pneumoniae subspecie pneumoniae producing extended spectrum beta-lactamases. Rev Med Chil. 2004;132(10):1173\u20138.","journal-title":"Rev Med Chil"},{"key":"4847_CR33","doi-asserted-by":"publisher","first-page":"555","DOI":"10.2147\/IDR.S275852","volume":"14","author":"S Kareem","year":"2021","unstructured":"Kareem S, Kadmy I, Kazaal S, Mohammed A, Naji S, Makharita R, et al. Detection of GyrA and parc mutations and prevalence of Plasmid-Mediated quinolone resistance genes in Klebsiella pneumoniae. Infect Drug Resist. 2021;14:555\u201363.","journal-title":"Infect Drug Resist"},{"issue":"10","key":"4847_CR34","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1128\/AAC.44.10.2595-2599.2000","volume":"44","author":"K Poole","year":"2000","unstructured":"Poole K. Efflux-mediated resistance to fluoroquinolones in gram-positive bacteria and the mycobacteria. Antimicrob Agents Chemother. 2000;44(10):2595\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"4847_CR35","doi-asserted-by":"publisher","first-page":"38929","DOI":"10.1038\/srep38929","volume":"6","author":"R Wasfi","year":"2016","unstructured":"Wasfi R, Elkhatib WF, Ashour HM. Molecular typing and virulence analysis of multidrug resistant Klebsiella pneumoniae clinical isolates recovered from Egyptian hospitals. Sci Rep. 2016;6:38929.","journal-title":"Sci Rep"},{"issue":"9","key":"4847_CR36","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.3390\/antibiotics10091117","volume":"10","author":"A Davin-Regli","year":"2021","unstructured":"Davin-Regli A, Pages JM, Ferrand A. Clinical status of efflux resistance mechanisms in Gram-Negative bacteria. Antibiot (Basel). 2021;10(9):1117.","journal-title":"Antibiot (Basel)"},{"issue":"1","key":"4847_CR37","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1093\/jac\/dku340","volume":"70","author":"S Bialek-Davenet","year":"2015","unstructured":"Bialek-Davenet S, Lavigne JP, Guyot K, Mayer N, Tournebize R, Brisse S, Leflon-Guibout V, Nicolas-Chanoine MH. Differential contribution of acrab and OqxAB efflux pumps to multidrug resistance and virulence in Klebsiella pneumoniae. J Antimicrob Chemother. 2015;70(1):81\u20138.","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"4847_CR38","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1089\/mdr.2018.0414","volume":"25","author":"N Maurya","year":"2019","unstructured":"Maurya N, Jangra M, Tambat R, Nandanwar H. Alliance of efflux pumps with \u03b2-Lactamases in Multidrug-Resistant Klebsiella pneumoniae isolates. Microb Drug Resist. 2019;25(8):1155\u201363.","journal-title":"Microb Drug Resist"},{"issue":"5","key":"4847_CR39","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1093\/femsre\/fuz014","volume":"43","author":"M Laws","year":"2019","unstructured":"Laws M, Shaaban A, Rahman KM. Antibiotic resistance breakers: current approaches and future directions. FEMS Microbiol Rev. 2019;43(5):490\u2013516.","journal-title":"FEMS Microbiol Rev"},{"issue":"1","key":"4847_CR40","first-page":"12","volume":"31","author":"Y Liu","year":"2023","unstructured":"Liu Y, Breukink E, den Blaauwen T. Bacterial proton motive force as an unprecedented target to control antimicrobial resistance. Trends Microbiol. 2023;31(1):12\u201324.","journal-title":"Trends Microbiol"},{"issue":"1","key":"4847_CR41","first-page":"e03734","volume":"13","author":"S Meylan","year":"2022","unstructured":"Meylan S, Porter CBM, Yang JH, Belenky P, Collins JJ. Proton motive force underpins respiration-mediated potentiation of aminoglycoside lethality in pathogenic Escherichia coli. mBio. 2022;13(1):e03734\u201321.","journal-title":"mBio"},{"issue":"3","key":"4847_CR42","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1021\/acsinfecdis.3c00517","volume":"10","author":"N Compagne","year":"2024","unstructured":"Compagne N, Vieira Da Cruz A, Muller RT, Pradel E, Verbeken M. Extending the potency and lifespan of antibiotics: inhibitors of Gram-negative bacterial efflux pumps. ACS Infect Dis. 2024;10(3):890\u2013905.","journal-title":"ACS Infect Dis"},{"issue":"1","key":"4847_CR43","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1039\/D3MD00483J","volume":"15","author":"DU Behera","year":"2023","unstructured":"Behera DU, Gaur M, Sahoo M, Subudhi E, Subudhi BB. Development of pharmacophore models for AcrB protein and the identification of potential adjuvant candidates for overcoming efflux-mediated colistin resistance. RSC Med Chem. 2023;15(1):127\u201338.","journal-title":"RSC Med Chem"},{"key":"4847_CR44","doi-asserted-by":"crossref","unstructured":"Li Y, Cross TS, D\u00f6rr T. Analysis of AcrB in Klebsiella pneumoniae reveals natural variants promoting enhanced multidrug resistance. Res Microbiol 2022 Mar-Apr;173(3):103901.","DOI":"10.1016\/j.resmic.2021.103901"},{"issue":"4","key":"4847_CR45","doi-asserted-by":"publisher","first-page":"322","DOI":"10.4274\/jpr.galenos.2019.16362","volume":"6","author":"K Ghadiri","year":"2019","unstructured":"Ghadiri K, Akya A, Elahi A, Jafari S, Chegenelorestani R. Resistance to Ciprofloxacin and mutations in topoisomerase genes in E. coli and K. pneumoniae from pediatric utis. J Pediatr Res. 2019;6(4):322\u20138.","journal-title":"J Pediatr Res"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-026-04847-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-026-04847-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-026-04847-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T06:26:14Z","timestamp":1776666374000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12866-026-04847-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4847"],"URL":"https:\/\/doi.org\/10.1186\/s12866-026-04847-6","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]},"assertion":[{"value":"18 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"\u201cThe Ethics Committee of the Guillermo Almenara Irigoyen National Hospital approved the study exempt from informed consent due to the following: the unit of analysis of the study was the bacterial isolate obtained in the context of epidemiological surveillance of antimicrobial resistance in accordance with Technical Standard No. 753\u20132004 of the Ministry of Health of Peru and Directive No. 16 GCPS-EsSALUD-2016.\u201d","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"379"}}